CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring
- PMID: 30854886
- PMCID: PMC6835174
- DOI: 10.1177/1932296819832909
CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring
Abstract
Background: Continuous glucose monitors (CGM) are underutilized by individuals with type 1 diabetes (T1D), particularly during the adolescent years. Little is known about perceptions of CGM benefit and burdens, and few tools exist to quantify this information.
Methods: Two questionnaires were developed and validated-Benefit of CGM (BenCGM) and Burdens of CGM (BurCGM)-in a sample of adolescents ages 12-19 years involved in the T1D Exchange Registry. We chose to start the validation process with adolescents given their low CGM uptake and high risk for suboptimal glycemic outcomes. Exploratory and confirmatory factor analyses were conducted to confirm factor structure and select items. The resultant scales were tested for internal reliability and convergent/divergent validity with critical diabetes and quality of life outcomes: age, depression, diabetes distress, self-efficacy, technology attitudes, and diabetes technology attitudes.
Results: A total of 431 adolescents with T1D completed the questionnaires (51% female, mean age 16.3 ± 2.26, 83% white non-Hispanic, 70% having used CGM). Two single factor scales emerged, and scales were reduced to 8 items each. Those who perceived higher benefit of CGM exhibited lower diabetes distress, higher self-efficacy, and more positive attitudes toward technology. Those who perceived higher burden of CGM exhibited higher diabetes distress, lower self-efficacy, and less positive technology attitudes.
Conclusion: The BenCGM and BurCGM questionnaires each comprise 8-items that demonstrate robust psychometric properties for use in adolescents with T1D, and can be used to develop targeted interventions to increase CGM wear to improve diabetes management.
Keywords: adolescents; continuous glucose monitoring; technology; type 1 diabetes.
Conflict of interest statement
Figures
Similar articles
-
Using Cluster Analysis to Understand Clinician Readiness to Promote Continuous Glucose Monitoring Adoption.J Diabetes Sci Technol. 2018 Nov;12(6):1108-1115. doi: 10.1177/1932296818786486. Epub 2018 Jul 11. J Diabetes Sci Technol. 2018. PMID: 29991281 Free PMC article.
-
Perceived Burdens and Benefits Associated With Continuous Glucose Monitor Use in Type 1 Diabetes Across the Lifespan.J Diabetes Sci Technol. 2022 Jan;16(1):88-96. doi: 10.1177/1932296820978769. Epub 2020 Dec 24. J Diabetes Sci Technol. 2022. PMID: 33356514 Free PMC article.
-
Continuous Glucose Monitoring Associated With Less Diabetes-Specific Emotional Distress and Lower A1c Among Adolescents With Type 1 Diabetes.J Diabetes Sci Technol. 2018 Jul;12(4):792-799. doi: 10.1177/1932296818766381. Epub 2018 Mar 29. J Diabetes Sci Technol. 2018. PMID: 29595061 Free PMC article.
-
Diabetes technology and treatments in the paediatric age group.Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Int J Clin Pract Suppl. 2011. PMID: 21323816 Review.
-
Psychological Reactions Associated With Continuous Glucose Monitoring in Youth.J Diabetes Sci Technol. 2016 May 3;10(3):656-61. doi: 10.1177/1932296816638109. Print 2016 May. J Diabetes Sci Technol. 2016. PMID: 26969141 Free PMC article. Review.
Cited by
-
Making Diabetes Care Fit-Are We Making Progress?Front Clin Diabetes Healthc. 2021 Apr 16;2:658817. doi: 10.3389/fcdhc.2021.658817. eCollection 2021. Front Clin Diabetes Healthc. 2021. PMID: 36994329 Free PMC article.
-
Similar Perceptions on Continuous Glucose Monitor Use amongst Youth with Type 1 and Type 2 Diabetes.Pediatr Diabetes. 2023 Jun 19;2023:1979635. doi: 10.1155/2023/1979635. eCollection 2023. Pediatr Diabetes. 2023. PMID: 40303266 Free PMC article. Clinical Trial.
-
Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes.Curr Diab Rep. 2021 May 15;21(7):22. doi: 10.1007/s11892-021-01389-1. Curr Diab Rep. 2021. PMID: 33991264 Free PMC article. Review.
-
'I was ready for it at the beginning': Parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis.Diabet Med. 2021 Aug;38(8):e14567. doi: 10.1111/dme.14567. Epub 2021 Apr 21. Diabet Med. 2021. PMID: 33772862 Free PMC article. Clinical Trial.
-
Patient-Reported Usefulness and Challenges in Using Hypoglycemia-Informing Features of Continuous Glucose Monitors to Manage Hypoglycemia.Sci Diabetes Self Manag Care. 2023 Jun;49(3):229-238. doi: 10.1177/26350106231168859. Epub 2023 Apr 22. Sci Diabetes Self Manag Care. 2023. PMID: 37086168 Free PMC article.
References
-
- FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions. FDA press release, December 20, 2016.
-
- Tamborlane WV, Beck RW, Bode BW, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464-1476. - PubMed
-
- Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring (JDRF-CGM) trial. Diabetes Care. 2010;33:17-22. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical